ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

ClinicalTrials.gov ID: NCT02065622

Public ClinicalTrials.gov record NCT02065622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 5:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

Study identification

NCT ID
NCT02065622
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
952 participants

Conditions and interventions

Interventions

  • Adalimumab Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2014
Primary completion
Sep 4, 2019
Completion
Nov 10, 2019
Last update posted
Nov 22, 2020

2014 – 2019

United States locations

U.S. sites
42
U.S. states
24
U.S. cities
39
Facility City State ZIP Site status
Digestive Health Specialists of the Southeast /ID# 127844 Dothan Alabama 36305
Ucsd /Id# 122313 La Jolla California 92093
Rocky Mountain Clinical Resear /ID# 122180 Wheat Ridge Colorado 80033
Medical Research Ctr CT /ID# 122179 Hamden Connecticut 06518
Gastro Florida /ID# 170619 Clearwater Florida 33756
Research Associates of South Florida,LLC /ID# 170309 Miami Florida 33156
Gastroenterology Group Naples /ID# 127806 Naples Florida 34102
Shafran Gastroenterology Ctr /ID# 122320 Winter Park Florida 32789
Atlanta Gastro Assoc /ID# 122336 Atlanta Georgia 30342
Gastro Assoc of Central GA /ID# 122318 Macon Georgia 31201
Northwestern University Feinberg School of Medicine /ID# 122183 Chicago Illinois 60611-2927
University of Chicago /ID# 122302 Chicago Illinois 60637-1443
Carle Foundation Hospital /ID# 135955 Urbana Illinois 61801
Louisiana Research Ctr. LLC /ID# 141655 Shreveport Louisiana 71105-6800
University of Maryland Med Ctr /ID# 169734 Baltimore Maryland 21201
MGG Group, Inc.Chevy Chase Clinical Research /ID# 122238 Chevy Chase Maryland 20815
University of Michigan Hospitals /ID# 122240 Ann Arbor Michigan 48109
Mayo Clinic - Rochester /ID# 122244 Rochester Minnesota 55905-0001
Ctr for Digest and Liver Dis /ID# 122182 Mexico Missouri 65265
NYU Langone Long Island CRA /ID# 122177 Great Neck New York 11021
Icahn School of Med Mt. Sinai /ID# 127047 New York New York 10029
Charlotte Gastro Hepatology /ID# 122235 Charlotte North Carolina 28207
Wake Research Associates, LLC /ID# 122157 Raleigh North Carolina 27612
Consultants for Clinical Res /ID# 122304 Cincinnati Ohio 45219
Dayton Gastroenterology, Inc. /ID# 127804 Englewood Ohio 45415
Gastro United of Tulsa /ID# 125436 Tulsa Oklahoma 74135
The Oregon Clinic- Gastro West /ID# 135273 Portland Oregon 97225
University of Pittsburgh MC /ID# 122331 Pittsburgh Pennsylvania 15260
Erlanger Institute for Clinica /ID# 129009 Chattanooga Tennessee 37403
Gastro One /ID# 122339 Germantown Tennessee 38138
Vanderbilt Univ Med Ctr /ID# 125496 Nashville Tennessee 37232-0011
DHAT Research Institute /ID# 170616 Garland Texas 75044-2208
Biopharma Informatic Research /ID# 171150 Houston Texas 77024-2420
Austin Center for Clinical Research /ID# 125396 Pflugerville Texas 78660
Texas Digestive Disease Consul /ID# 141677 Southlake Texas 76092
Texas Digestive Disease Consul /ID# 141678 Southlake Texas 76092
Advanced Research Institute /ID# 126147 Ogden Utah 84403
University of Utah /ID# 122333 Salt Lake City Utah 84112-5500
New River Valley Research Inst /ID# 127801 Christiansburg Virginia 24073
University of Washington /ID# 169721 Seattle Washington 98109
WI Center for Advanced Res /ID# 122178 Milwaukee Wisconsin 53215
Froedtert & the Medical College of Wisconsin /ID# 122261 Milwaukee Wisconsin 53226-3522

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 131 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02065622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2020 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02065622 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →